3mvm: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
{{Seed}}
{{Seed}}
[[Image:3mvm.jpg|left|200px]]
[[Image:3mvm.png|left|200px]]


<!--
<!--
Line 31: Line 31:
[[Category: Serine/threonine-protein kinase]]
[[Category: Serine/threonine-protein kinase]]
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Transferase-transferase inhibitor complex]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Oct 13 10:47:55 2010''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Oct 27 11:27:21 2010''

Revision as of 08:16, 27 October 2010

File:3mvm.png

Template:STRUCTURE 3mvm

P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7V

Template:ABSTRACT PUBMED 20804198

About this Structure

3MVM is a 2 chains structure with sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  1. Liu C, Lin J, Wrobleski ST, Lin S, Hynes J, Wu H, Dyckman AJ, Li T, Wityak J, Gillooly KM, Pitt S, Shen DR, Zhang RF, McIntyre KW, Salter-Cid L, Shuster DJ, Zhang H, Marathe PH, Doweyko AM, Sack JS, Kiefer SE, Kish KF, Newitt JA, McKinnon M, Dodd JH, Barrish JC, Schieven GL, Leftheris K. Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[ 1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38alpha MAP kinase inhibitor for the treatment of inflammatory diseases. J Med Chem. 2010 Sep 23;53(18):6629-39. PMID:20804198 doi:10.1021/jm100540x

Page seeded by OCA on Wed Oct 27 11:27:21 2010

Proteopedia Page Contributors and Editors (what is this?)

OCA